ReviewCardiovascular diagnosis and therapy2011
The coronary slow flow phenomenon: characteristics, mechanisms and implications.
Review in Cardiovascular diagnosis and therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
90 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Antithrombotic Therapy in Coronary Artery Aneurysm, Ectasia, and Slow Flow: A Systematic Review.Clinical cardiology · 2026Pooled it
- Pooled it
- Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.Frontiers in pharmacology · 2022Pooled it
- Ranolazine effectively improves clinical symptoms in patients with slow flow coronary arteries: a randomized, double-blind, placebo-controlled clinical trial.Naunyn-Schmiedeberg's archives of pharmacology · 2025Trial
- Sildenafil's effectiveness in the primary coronary slow flow phenomenon: a pilot randomised controlled clinical trial.Open heart · 2024Trial
- Trial
- Association Between Pittsburgh Sleep Quality Index Scores and TIMI Frame Count-Defined Coronary Slow Flow Phenomenon in Patients with Nonobstructive Coronary Arteries: A Cross-Sectional Study.Journal of cardiovascular development and disease · 2026Article
- Combined Assessment of Immunonutritional Indices and the Triglyceride-Glucose Index in Coronary Slow Flow Phenomenon in a Non-Elderly Population.Journal of clinical medicine · 2026Article
- Coronary slow flow: role of systemic inflammation and biomarkers in its pathophysiology.BMC cardiovascular disorders · 2026Article
- Cold Contrast-Induced Coronary Slow Flow: A Preventable Pitfall in the Cath Lab.Balkan medical journal · 2026Article
- Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score as a Novel Biomarker for Predicting Coronary Slow Flow in Patients with Angina and/or Ischemia and Nonobstructive Coronary Arteries.Journal of clinical medicine · 2026Article
- Efficacy and safety of Shexiang Tongxin pill for coronary slow flow in angina patients.NPJ cardiovascular health · 2026Article
- Stress Hyperglycemia Ratio Outperforms Admission Glucose in Predicting Coronary Slow Flow in Patients with Type 2 Diabetes Mellitus.International journal of general medicine · 2026Article
- The Predictive Value of Atherogenic Index of Plasma for the Presence of Slow Coronary Flow Phenomenon in Patients with Chest Pain and No Obstructive Coronary Arteries: A Single-Center Retrospective Study.International journal of general medicine · 2026Article
- Unraveling the mechanism of curcumin in coronary slow flow phenomenon through network pharmacology and molecular docking.Scientific reports · 2025Article
- The Relationship Between Laboratory Parameters and Coronary Slow Flow.Journal of clinical medicine · 2025Article
- The uric acid to high density lipoprotein cholesterol ratio as a new indicator for predicting coronary slow flow phenomenon.BMC cardiovascular disorders · 2025Article
- Article
- The Role of Prognostic Nutritional Index in Predicting Coronary Slow Flow Phenomena.Diagnostics (Basel, Switzerland) · 2025Article
- Observational
30 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronary slow flow phenomenon (CSFP) is an important, angiographic entity characterized by delayed progression of the injected contrast medium through the coronary tree. It is a frequent finding, typically observed in patients presenting with acute coronary syndromes. Although it is well known to interventional cardiologists for approximately four decades, the pathogenic mechanisms remain unclear. The clinical implications are significant, with over 80% of patients experiencing recurrent chest pain, resulting in considerable impairment in quality of life. This article will address in detail the characteristics, possible mechanisms, and clinical implications of this entity to provide further insight into its clinical significance and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.